tryhabitual.comCrawled Nov 3, 2026
The programme uses digital tools to support diabetes remission and weight loss through virtual assistance.
The Wegovy and Mounjaro programmes use prescription GLP-1 medications to help users lose 15–20% of body weight.
The Habitual programme is based on clinical evidence for preventing and reversing type 2 diabetes.
Total diet replacement is proven to reverse type 2 diabetes and aid weight loss.
The page describes five ways to safely lower and manage blood sugar levels in type 2 diabetes.
Exante Diet have ceased trading and closed down. Habitual offers meal replacement soups and shakes packed with 26 essential vitamins and minerals, 19g of protein and at only 200kcal per serving.
The page explains how to take sustainable breaks while maintaining a healthy lifestyle for diabetes management.
The guide provides tips for managing type 2 diabetes through diet and blood sugar control.
The page explains how to safely switch between Mounjaro and Wegovy weight loss medications.
The page explains how to safely switch between Mounjaro and Wegovy.
The page compares Wegovy and Mounjaro in terms of effectiveness, cost, accessibility, and other factors.
The page compares Saxenda and Wegovy in terms of effectiveness, cost, accessibility, and other factors.
Dr. Silja Voolma discusses her work, support for Habitual, and the future of behavior change science in an interview.
The weight loss programmes offer meal replacement or medication options paired with behavior change and support.
The page provides pharmacy terms and details about prescription medications offered.
Habitual has raised £1 million in pre-seed funding to advance its weight loss solutions. The company focuses on innovative approaches to support users in achieving sustainable health outcomes. This funding round marks a key milestone for Habitual’s growth and development.
Apr 2025StartupMagNews article
Habitual secures £1 million in funding to expand its weight loss solutions. The company targets growth amid rising demand, as over half a million Brits receive prescriptions for drugs like Wegovy and Mounjaro. Habitual also appoints a new chair to support its scaling efforts.
Apr 2025BusinessCloudNews article
Habitual secures a seven-figure investment from established investors to expand amid rising demand for sustainable weight loss solutions. The funding follows the surge in prescription weight-loss drugs like Wegovy, positioning Habitual to compete in the growing market. The company focuses on alternatives to pharmaceutical interventions, targeting long-term lifestyle changes.
Apr 2025Yahoo News UKNews article
Habitual Health secures £1.7 million in seed follow-on funding from Atlantic Food Labs to advance its digital health solutions. The startup focuses on delivering diabetes management tools directly to consumers, aiming to support reversal efforts through technology-driven interventions. Habitual Health previously raised $2.3 million in funding, indicating strong investor interest in its approach.
Oct 2021uktechnews.infoNews article
